[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"trigger-point-pain-myofascial\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:trigger-point-pain-myofascial":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,56,83,109,142,168,195],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100637000","evaluation-of-the-effect-of-adding-sodium-bicarbonate-to-lidocaine-in-the-treatment-of-myofascial-pain-syndrome-100637000",false,"NCT07572994","Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome","Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome Using Surface Electromyography (sEMG)","BIC-LIDO-MPS","Inclusion Criteria:\n\nPatients aged 16 to 70 years Clinical diagnosis of myofascial pain syndrome (MPS) Presence of active myofascial trigger points Pain duration ≥ 3 months Pain intensity ≥ 4 on the Visual Analog Scale (VAS) Trigger points located in accessible muscles No trigger point injection in the affected area within the past 3 months Ability and willingness to provide informed consent Willingness to comply with study procedures and follow-up visits\n\nExclusion Criteria:\n\nKnown allergy or hypersensitivity to lidocaine, sodium bicarbonate, or other amide-type local anesthetics Current use of anticoagulants or presence of bleeding disorders Local or systemic infection at or near the injection site History of fibromyalgia, cancer-related pain, or central pain syndromes Major psychiatric disorders (e.g., schizophrenia, severe depression) Recent trauma or surgery to the neck, shoulder, or back within the past 6 months Use of analgesics (e.g., NSAIDs, opioids) within 5 days prior to injection Severe systemic diseases (e.g., uncontrolled diabetes, liver failure, kidney failure, severe cardiovascular disease)\n\n\\-","ALL","16 Years","70 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study is designed to evaluate a method to improve the treatment of myofascial pain syndrome (MPS), a common condition that causes muscle pain, tenderness, and reduced movement due to the presence of trigger points in muscles.\n\nA commonly used treatment for this condition is the injection of a local anesthetic called lidocaine into these trigger points to relieve pain. However, the pain relief from lidocaine alone may be temporary.\n\nIn this study, we are investigating whether adding a small amount of sodium bicarbonate to lidocaine can improve its effectiveness. Sodium bicarbonate may reduce the pain during injection and help the anesthetic work faster and possibly last longer.\n\nParticipants in this study will be randomly assigned into one of two groups:\n\nOne group will receive lidocaine alone. The other group will receive lidocaine mixed with sodium bicarbonate.\n\nThe injection will be performed once into the painful muscle trigger points under sterile conditions.\n\nPain levels will be assessed using a simple pain scale, and muscle activity will be measured using a non-invasive technique called surface electromyography (sEMG), which records muscle electrical activity. These measurements will be taken before the injection, immediately after, and during follow-up visits.\n\nParticipants may experience mild discomfort during or after the injection, but all procedures are routinely used in clinical practice. Safety measures will be in place to manage any possible side effects.\n\nThe goal of this study is to determine whether the combined injection provides better pain relief, improves muscle function, and enhances patient comfort compared to lidocaine alone.",[28,29,30,31,32],"Myofacial Pain","Myofacial Pain Syndrome","Myofacial Pain Syndromes","Trigger Point Pain, Myofascial","Myofascial Pain Dysfunction Syndrome",[34,35,36,37,38,39,40,41,42,43],"lidocaine","Sodium Bicarbonate","Buffered Lidocaine","Trigger Point Injection","Surface Electromyography","Myofascial Trigger Points","Muscle Pain","Injection Pain","Muscle Activity","Musculoskeletal Pain","NOT_YET_RECRUITING","2026-05-01",{"date":47,"type":48},"2026-05-07","ACTUAL",{"date":45,"type":22},{"date":51,"type":22},"2026-10-01",{"name":53,"class":54},"Cairo University","OTHER",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":4,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":4,"studyType":23,"phases":68,"briefSummary":69,"conditions":70,"keywords":71,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":55},"100603614","effect-of-met-vs-neck-calliet-exercises-on-neck-pain-and-disability-in-nurses-100603614","NCT07138807","Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses","Comparative Effectiveness of Muscle Energy Technique and Neck Calliet Exercises on Mechanical Neck Pain and Disability Due to Trapezius Trigger Point Among Nurses","Inclusion Criteria:\n\n* Female nurses\n* Between 18 and 30 years of age\n* Having mechanical neck discomfort that is confined to the cervical or bilateral scapular regions (pain level must be 3-5 VAS)\n* There must be at least one trigger point in trapezius muscle\n* The participant must be ready to participate No clinical therapy for neck pain must have been performed in the preceding month\n\nExclusion Criteria:\n\n* A recent medical history including surgery on the shoulder or neck\n* Signs of myelopathy in the clinic or radiculopathy\n* Diagnosed Fibromyalgia syndrome, psychiatric problems\n* Pregnancy\n* Cervical stenosis, malignancy (cervical, breast cancer)\n* Thoracic outlet syndrome\n* Vestibulobasilar artery syndrome\n* Whiplash injury\n* Diagnosis of migraine\n* Diabetes type I, systematic illness of cardio-respiratory system\n* Congenital deformities affecting the spine, shoulders, and limbs\n* Osteoporosis of cervical spine or cervical myeloma","FEMALE","18 Years","30 Years",{"count":67,"type":22},38,[25],"This study compares the effectiveness of Muscle Energy Techniques (MET) and Neck Calliet Exercises in managing mechanical neck pain and associated disability due to trapezius trigger points among nurses. A total of 38 female nurses were randomly assigned to two intervention groups, each receiving therapy for four weeks. Pain, cervical range of motion, and disability outcomes were assessed.",[31],[72],"MET, Neck Calliet Exercise, Cervical ROM, VAS, NDI","RECRUITING","2025-09-11",{"date":76,"type":48},"2025-09-12",{"date":78,"type":48},"2025-08-15",{"date":80,"type":22},"2025-09-30",{"name":82,"class":54},"University of Faisalabad",{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":17,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":4,"studyType":23,"phases":94,"briefSummary":95,"conditions":96,"keywords":97,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":55},"100591921","strain-counterstrain-technique-and-graston-technqiue-on-quadratus-lumborum-trigger-points-100591921","NCT06986707","Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points","Comparative Effects of Strain Counterstrain Technique and Graston Technique on Trigger Points of Quadratus Lumborum Among Patients With Nonspecific Low Back Pain","Inclusion Criteria:\n\n* Participant's age range 20-45 years\n* Both genders.\n* Individuals having low back pain for atleast 12 weeks with limited segmental mobility especially after maintaining certain prolonged posture .\n* Individuals with localized pain and tenderness at attachments of quadratus lumborum due to the presence of trigger points (unilateral or bilateral).\n* positive segmental mobility assessment at the level of L4 and L5 on one side or on both sides\n* Patients having moderate pain on NPRS\n\nExclusion Criteria:\n\n* Individuals with anticoagulation or bleeding disorders, acute muscle trauma, infections, lumbar disc herniation, spinal deformities, or a history of spinal surgery or anticoagulation medication\n* Orthopedic surgery or any other low back surgery .\n* Fracture of vertebrae and any lower limb injury","20 Years","45 Years",{"count":93,"type":22},34,[25],"Poor body mechanics and posture affects body positioning and stresses quadratus lumborum muscle which ultimately leads to myofascial trigger points in muscle. This study aims to compare the effects of Strain counterstrain technique and Graston technique on trigger points of quadratus lumborum in nonspecific low back patients. This study will be a randomized controlled trial and will be conducted in Riphah Rehabilitation Clinic Lahore and SPARC Physiotherapy Clinic Lahore. Non-probability convenient sampling will be used to collect the data. Sample size of 34 subjects with age group between 20-45 years will be taken. baseline and after 4 weeks. Data analysis will be done by SPSS version 25.",[31],[98,99],"low back pain","quadratus lumborum","2025-07-03",{"date":102,"type":48},"2025-07-04",{"date":104,"type":48},"2025-06-12",{"date":106,"type":22},"2025-12-01",{"name":108,"class":54},"Riphah International University",{"id":110,"slug":111,"hasResults":11,"nctId":112,"briefTitle":113,"officialTitle":114,"acronym":4,"eligibilityCriteria":115,"healthyVolunteers":11,"sex":17,"minAge":64,"maxAge":116,"enrollmentInfo":117,"targetDuration":4,"studyType":23,"phases":119,"briefSummary":120,"conditions":121,"keywords":126,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":135,"completionDateStruct":137,"leadSponsor":139,"locationsCount":55},"100597449","efficacy-of-adding-greater-occipital-nerve-block-to-trigger-point-injection-in-patients-with-neck-pain-100597449","NCT07058636","Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain","Evaluation of the Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain and Upper Trapezius Trigger Points: A Single-Blind Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged between 18 and 65 years.\n* Diagnosed with myofascial pain syndrome (MPS) based on the major and minor criteria described by Travell and Simons (a diagnosis requires all 5 major and at least 1 minor criterion)\n* Presence of active trigger points in the upper trapezius muscle.\n* Patients with neck pain lasting longer than 3 months.\n* Pain intensity of ≥5 on the Visual Analog Scale (VAS).\n\nExclusion Criteria:\n\n* Elderly, pediatric, pregnant, postpartum, or breastfeeding individuals; patients in intensive care; unconscious individuals; or legally incapacitated persons.\n* Known allergy to local anesthetics used in trigger point injection (e.g., lidocaine, bupivacaine) or to other drugs used (e.g., corticosteroids).\n* Patients with bleeding disorders (e.g., hemophilia, thrombocytopenia) or those currently on anticoagulant therapy.\n* Presence of active infection at or near the injection site, or any systemic infection; impaired skin integrity.\n* Patients with psychiatric disorders that may interfere with treatment response or affect study outcomes.\n* Patients with severe neurological or cardiovascular disorders, or with uncontrolled diabetes.\n* Patients with cervical disc pathologies with radiculopathy.\n* History of receiving shoulder injection, trigger point injection, dry needling, manual therapy, or electrotherapy within the past 3 months.\n* History of cervical or shoulder surgery.\n* Patients diagnosed with adhesive capsulitis, rotator cuff tendinopathy, or shoulder impingement syndrome.\n* Diagnosis of fibromyalgia.\n* Presence of active trigger points in other back muscles.","65 Years",{"count":118,"type":22},60,[25],"Study Title:\n\nEvaluation of the Effectiveness of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients with Neck Pain Due to Upper Trapezius Trigger Points: A Single-Blind Randomized Controlled Trial\n\nPurpose of the Study:\n\nThis study aims to evaluate whether adding a Greater Occipital Nerve (GON) block to the standard trigger point injection treatment provides better pain relief and improves daily function in patients with neck pain caused by trigger points in the upper trapezius muscle. Trigger points are small, sensitive spots in muscles that can cause significant pain and discomfort. While both trigger point injections and GON blocks are common treatments for neck and head pain, it is not yet clear if combining these two methods offers better results.\n\nWhy is this study important? Neck pain related to trigger points in the upper trapezius muscle is a frequent problem, but there is limited research on the effectiveness of combining trigger point injections with GON blocks. This study will provide important information on whether the combination therapy can reduce pain more effectively and improve patients' quality of life and ability to perform daily activities.\n\nWho can participate?\n\nAdults aged 18 to 65 years old\n\nDiagnosed with myofascial pain syndrome (MAS) based on specific clinical criteria, including the presence of trigger points in the upper trapezius muscle\n\nExperiencing neck pain lasting longer than 3 months\n\nPain intensity rated 5 or higher on a scale of 0 to 10\n\nWho cannot participate?\n\nPregnant or breastfeeding women, children, elderly people, unconscious or critically ill patients\n\nPatients with allergies to local anesthetics or steroids\n\nIndividuals with bleeding disorders or infections near the injection site\n\nPatients with serious psychiatric or neurological diseases, or other medical conditions that may affect study results\n\nThose who have recently received similar treatments or surgery for neck or shoulder problems\n\nStudy Design and Procedures:\n\nThe study will include 60 patients meeting the criteria, randomly assigned to two groups using a balanced randomization method.\n\nGroup A will receive only trigger point injections into the upper trapezius muscle using a mixture of lidocaine and saline solution.\n\nGroup B will receive both trigger point injections and an ultrasound-guided GON block, which involves injecting a combination of local anesthetics and steroid near the greater occipital nerve to reduce pain signals.\n\nBoth groups will receive the same home exercise program focusing on stretching and strengthening neck muscles to support recovery. Patients will be encouraged to perform these exercises regularly and will be followed up weekly by phone to check their progress.\n\nThe doctor assessing patients' progress will not know which treatment the patient received, to ensure unbiased results.\n\nAssessments:\n\nPatients will be evaluated at three different times: before treatment, 1 week after treatment, and 4 weeks after treatment. Assessments include:\n\nPain intensity and quality (using Visual Analog Scale and McGill Pain Questionnaire)\n\nNeck disability and ability to perform daily activities (Neck Disability Index)\n\nQuality of life (Nottingham Health Profile)\n\nNeck joint movement and position sense (using clinical tests with special equipment)\n\nPosture evaluation (measuring head position using photography)\n\nExpected Outcomes:\n\nThe main goal is to determine if the combined treatment of trigger point injection plus GON block is more effective than trigger point injection alone in reducing pain, improving neck function, and enhancing quality of life.\n\nDuration and Follow-Up:\n\nThe study is planned to last 12 months. Patients will be closely monitored during and after treatment to ensure safety and to collect necessary data.\n\nPotential Benefits and Risks:\n\nParticipants may experience pain relief and improved function if the combined treatment is effective. Risks include mild discomfort or side effects related to injections, which will be minimized by experienced medical staff.",[122,29,31,123,124,125],"Neck Pain","Trigger Points","Upper Trapezius Trigger Points","Cervicogenic Headache",[127,128,129,130,131],"neck pain","myofascial pain syndrome","trigger point injection","ultrasound guided occipital nerve block","upper trapezius trigger point","2025-07-01",{"date":134,"type":48},"2025-07-10",{"date":136,"type":48},"2025-04-03",{"date":138,"type":22},"2026-04",{"name":140,"class":141},"Ankara Etlik City Hospital","OTHER_GOV",{"id":143,"slug":144,"hasResults":11,"nctId":145,"briefTitle":146,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":11,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":149,"targetDuration":4,"studyType":23,"phases":151,"briefSummary":152,"conditions":153,"keywords":156,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":167},"100540418","clinical-study-on-dry-needling-for-primary-dysmenorrhea-and-its-preliminary-correlation-with-acupoints-100540418","NCT06316583","Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints","Clinical Study of Dry Needling on Myofascial Trigger Points Treatment for Primary Dysmenorrhea and Preliminary Investigation of Its Relevance to Acupoints","Inclusion Criteria:\n\n1. All participants diagnosed explicitly by a gynecologist as having primary dysmenorrhea without pelvic organic lesions.\n2. Aged between 18 and 30 years.\n3. A history of cyclical menstrual pain for more than 2 years.\n4. Pain greater than 30mm on the Visual Analog Scale (VAS, 0-100mm).\n5. Participants must sign an informed consent form and be willing to undergo acupuncture treatment and cooperate to complete the relevant procedures of this trial.\n\nExclusion Criteria:\n\n1. Those suffering from secondary dysmenorrhea or any other reproductive and urinary system diseases, such as endometriosis.\n2. A history of pregnancy, miscarriage, or planning for pregnancy. Individuals with skin infections on the abdomen and lower back.\n3. Past use of acupuncture therapy or other needling treatments.\n4. Those with a history of mental illness and severe diseases of the heart, liver, brain, kidneys, hematopoietic system, etc.\n5. Within the past 6 months, individuals referred to pain clinics, those who have used pain relievers like morphine or pethidine, or those allergic to NSAIDs. Also, those currently taking or receiving anticoagulant medications.\n6. Individuals who have had adverse reactions to acupuncture (e.g., fainting).",{"count":150,"type":22},150,[25],"Primary dysmenorrhea refers to menstrual pain not caused by pelvic organic lesions, commonly seen in young women, significantly affecting patients' quality of life. Dry needling therapy targeting myofascial trigger points for primary dysmenorrhea has been preliminarily applied in clinical settings. However, related research is limited with questionable quality, hindering its widespread clinical application. Furthermore, is there a connection between myofascial trigger points in dry needling and acupuncture acupoints in terms of selection and mechanism of action? Could this be a new interpretation of acupuncture theory? These are important questions that have garnered widespread attention. This study employs a randomized patient-blinded controlled design, enrolling primary dysmenorrhea patients aged 18 to 30 years. They are randomly divided into three groups: the trigger point dry needling group, traditional acupuncture treatment group, and trigger point sham needle (placebo) group. Changes in pain levels, quality of life scores, inflammatory factor levels, and local blood flow before and after treatment among the three groups are observed. The aim is to assess the therapeutic effects of dry needling trigger points and acupuncture treatments on primary dysmenorrhea and explore their potential mechanisms of action. By comparing the differences and similarities between dry needling trigger points and acupuncture treatments in terms of acupoint selection, treatment effects, and potential mechanisms of action, this study seeks to preliminarily explore the feasibility of integrating trigger point theory into the meridian 'acupoint' theory, laying the foundation for a modern interpretation of acupuncture",[31,154,155],"Acupuncture","Primary Dysmenorrhea",[157],"trigger points, dry-needling, primary dysmenorrhea","2025-05-17",{"date":160,"type":48},"2025-05-21",{"date":162,"type":48},"2024-04-01",{"date":164,"type":22},"2026-12-31",{"name":166,"class":141},"Beijing Hospital",2,{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":4,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":17,"minAge":64,"maxAge":116,"enrollmentInfo":175,"targetDuration":177,"studyType":178,"phases":4,"briefSummary":179,"conditions":180,"keywords":181,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":186,"lastUpdatePostDateStruct":187,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":55},"100567144","safe-zone-in-trigger-point-injection-100567144","NCT06664359","Safe Zone in Trigger Point Injection","Avoid Pneumothorax: Identification of the Interscapular Area Trigger Point Injection Safe Zone in Different Positions (Sitting\u002FProne)","Inclusion Criteria:\n\n* patients diagnosed with Myofascial Pain Syndrome\n* patients scheduled for trigger point injections due to Myofascial Pain Syndrome.\n\nExclusion Criteria:\n\n* under 18 years of age,\n* additional diseases other than Myofascial Pain Syndrome,\n* the presence of active infection in the interscapular area where ultrasound imaging and measurements will be performed,\n* lesions that disrupt skin integrity or affect subcutaneous and muscle structures such as anomalies or masses that could impair imaging quality\n* individuals with known lung diseases\n* not consent to participate in the study.\"",{"count":176,"type":22},211,"1 Day","OBSERVATIONAL","The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question\\[s\\] it aims to answer \\[is\u002Fare\\]:\n\nThe mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation",[31],[182,183,184,185],"Trigger Point Pain","Myofascial pain","ultrasound","pneumothorax","2024-10-28",{"date":188,"type":48},"2024-10-29",{"date":190,"type":48},"2024-10-01",{"date":192,"type":22},"2024-12-30",{"name":194,"class":54},"Ankara University",{"id":196,"slug":197,"hasResults":11,"nctId":198,"briefTitle":199,"officialTitle":199,"acronym":4,"eligibilityCriteria":200,"healthyVolunteers":11,"sex":17,"minAge":201,"maxAge":116,"enrollmentInfo":202,"targetDuration":4,"studyType":23,"phases":203,"briefSummary":204,"conditions":205,"keywords":4,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":207,"lastUpdatePostDateStruct":208,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":213,"locationsCount":4},"100559071","subthreshold-stimulation-versus-suprathreshold-stimulation-in-people-with-chronic-low-neck-pain-100559071","NCT06559358","Subthreshold Stimulation Versus Suprathreshold Stimulation in People With Chronic Low Neck Pain","Inclusion Criteria:\n\n* Age from 40 to 65 years old participated in this study, 2\n* Having neck pain for more than 6 months with a grade five or greater on the visual analog scale\n* Having one or more trigger points in the upper trapezius muscle,\n* A significant increase in neck muscle EMG activity indicates the presence of tender points.\n\nExclusion Criteria:\n\n* Taking non-pharmacological therapies (e.g., acupuncture, physical therapy, osteopathy)\n* Taking oral or intravenous pain therapy, intramuscular or subcutaneous injection of cortisone, or local anesthetics during the study period,\n* Presence of any contraindication to electrical current including pregnancy, epilepsy, cardiac arrhythmia, cardiac surgery, implanted pacemaker or defibrillator, previous surgery in the spinal cord, infectious diseases of the spinal cord, malignant tumors with or without secondary blastomas in the spinal cord, severe radicular pain with acute paralysis in the extremities","40 Years",{"count":118,"type":22},[25],"this trial will involve three groups. Group 1 will receive subthreshold stimulation. Group 2 will receive suprathreshold stimulation. Group 3 will receive shame treatment.",[206,31],"Pain","2024-08-16",{"date":209,"type":48},"2024-08-19",{"date":211,"type":22},"2024-09-01",{"date":192,"type":22},{"name":214,"class":54},"Beni-Suef University"]